Telegram
Infinity Pharmaceuticals INFI
$ 0.04
-46.98%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиInfinity Pharmaceuticals Мультипликаторы 2011-2024 | INFI
Мультипликаторы по годам Infinity Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.4 | -4.3 | -4.9 | -1.7 | -6.1 | -2.5 | -3.3 | -2.4 | -43.1 | -5.1 | -19.6 | -4.0 |
P/S |
6.5 | 103.7 | 116.0 | 26.0 | 3.1 | 17.4 | 5.3 | 2.8 | 4.5 | - | 22.5 | 1.7 |
EPS |
-0.5 | -0.5 | -0.7 | -0.8 | -0.2 | -0.8 | -0.6 | -2.6 | -0.4 | -2.6 | -1.7 | -1.5 |
EV (Enterprise Value) |
39.8 млн | 175 млн | 233 млн | 98.2 млн | 27.9 млн | 81.2 млн | 68.4 млн | 307 млн | 602 млн | 614 млн | 908 млн | 245 млн |
EBITDA per Share |
-0.5 | -0.52 | -0.662 | -0.798 | -0.212 | -0.687 | -2.82 | -2.54 | -0.127 | -2.63 | -3.08 | -1.37 |
EV/EBITDA |
-3.4 | -5.8 | -1.9 | -1.7 | -2.2 | -0.2 | -0.9 | -71.9 | -4.8 | -9.0 | -4.8 | |
PEG |
-0.01 | -0.23 | 0.27 | -0.01 | 0.08 | -0.07 | 0.04 | -0.0 | 0.5 | -0.09 | -1.47 | 0.21 |
P/B |
-0.9 | 8.9 | -8.7 | 10.3 | 1.3 | 2.2 | 1.2 | 3.1 | 3.6 | 3.2 | 3.4 | 10.4 |
P/CF |
-0.4 | -4.7 | -5.6 | -1.8 | -14.6 | -2.8 | -0.6 | -3.4 | 6.4 | -5.6 | -13.0 | -4.6 |
ROE % |
232.90 | -209.83 | 176.14 | -609.07 | -21.45 | -87.64 | -36.51 | -130.26 | -8.31 | -62.99 | -17.40 | -259.45 |
ROA % |
-105.26 | -53.38 | -102.98 | -96.01 | -18.69 | -70.48 | -23.96 | -44.45 | -4.72 | -54.95 | -16.08 | -32.16 |
ROCE % |
235.39 | -209.00 | -136.17 | -116.15 | -22.72 | -76.31 | -140.59 | -58.10 | -2.52 | -61.23 | -31.28 | -40.34 |
Current Ratio |
0.7 | 1.3 | 3.3 | 4.6 | 7.8 | 5.0 | 4.3 | 3.6 | 6.3 | 10.1 | 17.7 | 4.1 |
DSO |
- | - | - | - | - | - | 1.7 | 4.0 | 1.4 | - | - | 0.9 |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | 1049.6 | 81.0 | 6332.0 | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | -1049.6 | -81.0 | -6332.0 | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Infinity Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.11 | -0.12 | - | -0.12 | -0.13 | -0.14 | - | -0.12 | -0.13 | -0.15 | - | -0.16 | -0.16 | -0.19 | - | -0.2 | -0.18 | -0.24 | - | 0.23 | -0.12 | -0.18 | -0.14 | -0.14 | -0.34 | -0.21 | -0.46 | -0.39 | 1.05 | -0.82 | -0.8 | 0.85 | -0.78 | -1.91 | -0.83 | 2.08 | -0.78 | -0.87 | -0.68 | -0.71 | -0.68 | -0.57 | -1.15 | 0.57 | -0.54 | -0.4 | -0.53 | -0.45 | -0.44 | -0.09 |
EBITDA per Share |
- | -0.13 | - | -0.12 | -0.13 | -0.14 | - | -0.12 | -0.12 | -0.15 | - | -0.14 | -0.15 | -0.18 | - | -0.18 | -0.17 | -0.24 | - | 0.23 | -0.13 | -0.18 | -0.16 | -0.12 | -0.17 | -0.19 | -0.46 | -0.35 | 1.1 | -0.81 | -0.8 | 0.91 | -0.77 | -1.89 | -0.8 | 2.24 | -0.71 | -0.84 | -0.69 | -0.68 | -0.67 | -0.57 | -1.15 | 0.62 | -0.5 | -0.36 | -0.51 | -0.37 | -0.38 | -0.05 |
ROE % |
262.73 | 1318.86 | 1056.72 | 1023.39 | 891.51 | -218.37 | -82.80 | -41.33 | 33.47 | 101.81 | 130.03 | -17.74 | -206.99 | -384.28 | -461.75 | -436.24 | -262.96 | -140.15 | -5.78 | -21.07 | -61.46 | -83.71 | -87.64 | -100.16 | -108.92 | -9.14 | -36.51 | -48.46 | 18.35 | -84.90 | -130.26 | -109.75 | -103.64 | -82.80 | -8.31 | -5.41 | -71.55 | -69.59 | -62.99 | -61.78 | -38.98 | -27.52 | -17.40 | -93.36 | -176.69 | -247.97 | -259.46 | -77.40 | -76.01 | -14.94 |
ROA % |
-125.31 | -97.80 | -57.28 | -68.61 | -59.16 | -50.76 | -32.65 | -56.90 | -69.83 | -82.93 | -76.03 | -99.32 | -98.37 | -95.72 | -72.79 | -50.56 | -5.05 | 4.84 | -5.04 | -17.33 | -51.52 | -68.52 | -70.48 | -76.43 | -79.98 | -9.24 | -23.96 | -19.28 | 10.97 | -44.51 | -44.45 | -41.81 | -28.58 | -25.57 | -4.72 | -8.06 | -50.73 | -54.56 | -54.95 | -54.68 | -34.49 | -24.73 | -16.08 | -13.37 | -28.45 | -33.51 | -32.16 | -9.60 | -9.42 | -1.85 |
ROCE % |
267.81 | 1326.39 | 1061.41 | 1027.96 | 894.46 | -218.26 | -82.78 | -44.31 | 27.61 | 93.49 | 122.95 | -14.01 | -189.44 | -354.36 | -441.48 | -416.36 | -254.29 | -141.75 | -6.62 | -23.42 | -64.98 | -72.55 | -76.36 | -87.73 | -95.47 | -9.97 | -37.46 | -49.02 | 19.05 | -84.44 | -128.97 | -107.90 | -100.38 | -78.04 | -3.78 | -1.55 | -69.95 | -69.40 | -63.43 | -62.19 | -39.16 | -27.49 | -17.02 | -90.03 | -171.14 | -240.18 | -249.65 | -75.05 | -73.65 | -12.75 |
Current Ratio |
0.4 | 0.5 | 0.7 | 0.8 | 1.0 | 1.2 | 1.3 | 1.5 | 1.7 | 1.9 | 0.6 | 0.6 | 0.6 | 0.6 | 1.2 | 1.2 | 1.2 | 1.2 | 7.8 | 7.8 | 7.8 | 7.8 | 5.1 | 5.1 | 5.1 | 5.1 | 2.9 | 2.9 | 2.9 | 2.9 | 1.5 | 1.5 | 1.5 | 1.5 | 2.3 | 2.3 | 2.3 | 2.3 | 7.8 | 7.8 | 7.8 | 7.8 | 13.2 | 13.2 | 13.2 | 13.2 | 1.1 | 1.1 | 1.1 | 1.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD